200
Participants
Start Date
November 9, 2023
Primary Completion Date
July 21, 2026
Study Completion Date
August 18, 2026
SAR444656 (KT-474)
Oral Tablet
Placebo
Oral Tablet
Investigational Site Number : 2760001, Berlin
UPMC Montefiore- Site Number : 8400006, Pittsburgh
Investigational Site Number : 4100001, Ansan-si
Investigational Site Number : 2760002, Buxtehude
Encore Medical Research - 6600 Taft St- Site Number : 8400004, Hollywood
Revival Research - Doral- Site Number : 8400007, Doral
Sullivan Dermatology- Site Number : 8400001, Miami
Encore Medical Research - Weston- Site Number : 8400008, Weston
Encore Medical Research of Boynton Beach- Site Number : 8400002, Boynton Beach
Investigational Site Number : 2760006, Remscheid
Investigational Site Number : 2760003, Bochum
Wayne Health - Dearborn- Site Number : 8400009, Dearborn
Investigational Site Number : 2760008, Frankfurt am Main
Investigational Site Number : 2760007, Heidelberg
Investigational Site Number : 2760009, Munich
Clear Dermatology & Aesthetics Center- Site Number : 8400003, Scottsdale
Investigational Site Number : 4100002, Cheonan-si
ARA Professionals- Site Number : 8400017, Miami
ACRC Trials - Carrollton - Hunt - PPDS- Site Number : 8400012, Carrollton
Investigational Site Number : 2030002, Ostrava
Investigational Site Number : 2030001, Pardubice
Investigational Site Number : 2030003, Prague
Investigational Site Number : 2760010, Dessau
Investigational Site Number : 3000001, Pavlos Melas
Investigational Site Number : 3000002, Thessaloniki
Investigational Site Number : 6160006, Tarnów
Investigational Site Number : 6160012, Wroclaw
Investigational Site Number : 6160002, Wroclaw
Investigational Site Number : 6160011, Lodz
Investigational Site Number : 6160001, Lodz
Investigational Site Number : 6160007, Warsaw
Investigational Site Number : 6160005, Warsaw
Investigational Site Number : 6160003, Chojnice
Investigational Site Number : 6160004, Gdansk
Investigational Site Number : 6160009, Katowice
Investigational Site Number : 6160010, Lodz
Investigational Site Number : 4100004, Seongbuk-Gu
Lead Sponsor
Collaborators (1)
Kymera Therapeutics, Inc.
INDUSTRY
Sanofi
INDUSTRY